Xencor | Resultat Før Skatt



Pre Tax Profit Endring Dato
AbbVie USD 4.81B 1.54B 2024-12
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD -175115000 2.32M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Biogen USD 572.2M 118.5M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Cytokinetics USD -150020000 10.52M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
J&J USD 13.63B 8.21B 2025-03
MacroGenics USD -14477000 70.79M 2024-12
Merck USD 5.22B 114M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Xencor USD -52626000 6.33M 2024-12



Xencor Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.